-
Apr 12, 2024, 08:20 AM
by
Full story
-
Apr 12, 2024, 08:20 AM
by
Alfa Chemistry, a reliable chemical supplier, is pleased to announce the addition of a comprehensive range of derivatization reagents for use in Thin Layer Chromatography (TLC). These reagents are specifically designed to enhance the detection and analysis of compounds on TLC plates, enabling researchers to achieve better results in their experiments.
Full story
-
Apr 12, 2024, 08:20 AM
by
BOC Sciences, a globally renowned supplier with over a decade of experience in the biochemical supply chain, is thrilled to announce its participation in this year's TIDES USA or the Oligonucleotide and Peptide Therapeutics conference. The BOC Sciences team will showcase its cutting-edge products and services at booth #937.
Full story
-
Apr 12, 2024, 08:19 AM
by
Full story
-
Apr 12, 2024, 08:19 AM
by
Full story
-
Apr 12, 2024, 08:19 AM
by
Full story
-
Apr 12, 2024, 08:19 AM
by
Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, will present an in-depth exploration of medical device regulations, for pharmacovigilance professionals seeking mastery in compliance and operational excellence.
Full story
-
Apr 12, 2024, 08:19 AM
by
DNAnexus announced that its ongoing collaboration with UK Biobank will be recognized with the 2024 Innovative Best Practices Global Impact Award at the upcoming Bio-IT World Conference and Expo.
Full story
-
Apr 12, 2024, 08:19 AM
by
Full story
-
Apr 12, 2024, 08:19 AM
by
Luma Lab Connect automatically centralizes, parses, and models data from lab instruments and other data sources for deeper analysis and insights on one harmonized, low-code cloud platform.
Full story
-
Apr 11, 2024, 10:33 AM
by
User Not Found
Bio-IT World | Molecular biologists at Iowa State University report the potential for the effects of genetic mutations to be known using a “super minigene” system developed in the lab of Ravindra Singh, Ph.D., professor of biomedical sciences.
Full story
-
Apr 11, 2024, 08:47 AM
by
DNAnexus announced a collaboration with Oracle to advance precision health.
Full story
-
Apr 11, 2024, 08:47 AM
by
ProPharma announces changes to its executive leadership team with strategic appointments to propel global growth
Full story
-
Apr 11, 2024, 08:47 AM
by
Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announces its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms.
Full story
-
Apr 10, 2024, 08:21 AM
by
Bios Health Group Unveils Bios Innovation Circle™
Groundbreaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena
Full story
-
Apr 10, 2024, 08:21 AM
by
Full story
-
Apr 10, 2024, 06:00 AM
by
User Not Found
Bio-IT World | In drug discovery, the focus of machine learning and artificial intelligence tools has been on predicting outcomes without explanation or understanding of the biochemical pathways mediating those effects. But rigorous translation requires a solid science-based foundation to explain how a drug works, not just that it does.
Full story
-
Apr 9, 2024, 09:05 AM
by
Full story
-
Apr 9, 2024, 09:05 AM
by
Model Medicines has announced the upcoming release of two groundbreaking preprint papers on bioRxiv, detailing significant advances in antiviral and oncology drug discovery using their GALILEO AI platform. The first preprint reveals the discovery of a novel broad-spectrum antiviral target and inhibitor, while the second introduces ChemPrint, a deep learning model that achieved a remarkable 45.5% hit rate in identifying novel inhibitors of challenging oncology targets. These findings build upon Model Medicines' recent successes and underscore the transformative potential of their AI platform in revolutionizing drug discovery.
Full story
-
Apr 9, 2024, 09:05 AM
by
CG Life is acquiring Toolhouse, doubling agency size and strengthening expertise in creating
impactful digital experiences connecting with clinical and patient audiences.
Full story